Protein kinase R plays a pivotal role in oncostatin M and interleukin-1 signalling in bovine articular cartilage chondrocytes

European Cells and Materials

Volumn 23, Issue , 2012, Pages 41-57

  Gilbert, S J ^a   Blain, E J ^a   Al Sabah, A ^a   Zhang, Y ^a   Duance, V C ^a   Mason, D J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Aggrecanase; Articular cartilage; Chondrocytes; Interleukin 1; Matrix metalloproteinase; Oncostatin M; Protein kinase R; Tumour necrosis factor alpha; Type II collagen

Indexed keywords

AGGRECAN; AGGRECANASE 1; AGGRECANASE 2; COLLAGEN TYPE 11; COLLAGEN TYPE 2; COLLAGEN TYPE 9; GELATINASE B; INTERLEUKIN 1; MESSENGER RNA; ONCOSTATIN M; PROTEIN KINASE R; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CONTROLLED STUDY; COW; ENZYME INHIBITION; MONOLAYER CULTURE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 84863183489     PISSN: 14732262     EISSN: None     Source Type: Journal    
DOI: 10.22203/eCM.v023a04     Document Type: Article

References (58)

1. Barksby HE, Hui W, Wappler I, Peters HH, Milner JM, Richards CD, Cawston TE, Rowan AD (2006) Interleukin-1 in combination with oncostatin M upregulates multiple genes in chondrocytes: implications for cartilage destruction and repair. Arthritis Rheum 54: 540-550.
2. Besse S, Rebouillat D, Marie I, Puvion-Dutilleul F, Hovanessian AG (1998) Ultrastructural localization of interferon-inducible double-stranded RNA-activated enzymes in human cells. Exp Cell Res 239: 379-392.
3. Blain EJ, Gilbert SJ, Hayes AJ, Duance VC (2006) Disassembly of the vimentin cytoskeleton disrupts articular cartilage chondrocyte homeostasis. Matrix Biol 25: 398-408.
4. Blain EJ, Ali AY, Duance VC (2010) Boswellia frereana (frankincense) suppresses cytokine-induced matrix metalloproteinase expression and production of proinflammatory molecules in articular cartilage. Phytother Res 24: 905-912.
5. Blalock WL, Grimaldi C, Fala F, Follo M, Horn S, Basecke J, Martinelli G, Cocco L, Martelli AM (2009) PKR activity is required for acute leukemic cell maintenance and growth: a role for PKR-mediated phosphatase activity to regulate GSK-3 phosphorylation. J Cell Physiol 221: 232-241.
6. Blanchard F, Wang Y, Kinzie E, Duplomb L, Godard A, Baumann H (2001) Oncostatin M regulates the synthesis and turnover of gp130, leukemia inhibitory factor receptor alpha, and oncostatin M receptor beta by distinct mechanisms. J Biol Chem 276: 47038-47045.
7. Catterall JB, Carrere S, Koshy PJ, Degnan BA, Shingleton WD, Brinckerhoff CE, Rutter J, Cawston TE, Rowan AD (2001) Synergistic induction of matrix metalloproteinase 1 by interleukin-1alpha and oncostatin M in human chondrocytes involves signal transducer and activator of transcription and activator protein 1 transcription factors via a novel mechanism. Arthritis Rheum 44: 2296-2310.
8. Cawston TE, Ellis AJ, Humm G, Lean E, Ward D, Curry V (1995) Interleukin-1 and oncostatin M in combination promote the release of collagen fragments from bovine nasal cartilage in culture. Biochem Biophys Res Commun 215: 377-385.
9. Cawston TE, Curry VA, Summers CA, Clark IM, Riley GP, Life PF, Spaull JR, Goldring MB, Koshy PJ, Rowan AD, Shingleton WD (1998) The role of oncostatin M in animal and human connective tissue collagen turnover and its localization within the rheumatoid joint. Arthritis Rheum 41: 1760-1771.
10. Chiu S-C, Yang N-S (2007) Inhibition of tumor necrosis factor-{alpha} through selective blockade of pre-mRNA splicing by shikonin. Mol Pharmacol 71: 1640-1645.
11. Clemens MJ, Bushell M, Jeffrey IW, Pain VM, Morley SJ (2000) Translation initiation factor modifications and the regulation of protein synthesis in apoptotic cells. Cell Death Differ 7: 603-615.
12. Clemens MJ, Elia A (1997) The double-stranded RNAdependent protein kinase PKR: structure and function. J Interferon Cytokine Res 17: 503-524.
13. Durigova M, Soucy P, Fushimi K, Nagase H, Mort JS, Roughley PJ (2008) Characterization of an ADAMTS-5- mediated cleavage site in aggrecan in OSM-stimulated bovine cartilage. Osteoarthritis Cartilage 16: 1245-1252.
14. Durigova M, Troeberg L, Nagase H, Roughley PJ, Mort JS (2011) Involvement of ADAMTS5 and hyaluronidase in aggrecan degradation and release from OSM-stimulated cartilage. Eur Cell Mater 21: 31-45.
15. Ehashi T, Miyoshi H, Ohshima N (2005) Oncostatin M stimulates proliferation and functions of mouse fetal liver cells in three-dimensional cultures. J Cell Physiol 202: 698-706.
16. El Mabrouk M, Sylvester J, Zafarullah M (2007) Signaling pathways implicated in oncostatin M-induced aggrecanase-1 and matrix metalloproteinase-13 expression in human articular chondrocytes. Biochim Biophys Acta 1773: 309-320.
17. Fearon U, Mullan R, Markham T, Connolly M, Sullivan S, Poole AR, FitzGerald O, Bresnihan B, Veale DJ (2006) Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures. Arthritis Rheum 54: 3152-3162.
18. Feldmann M, Maini RN (1999) The role of cytokines in the pathogenesis of rheumatoid arthritis. Rheumatology (Oxford) 38 Suppl 2: 3-7.
19. Frye SR, Yee A, Eskin SG, Guerra R, Cong X, McIntire LV (2005) cDNA microarray analysis of endothelial cells subjected to cyclic mechanical strain: importance of motion control. Physiol. Genomics 21: 124-130.
20. Gilbert SJ, Duance VC, Mason DJ (2002) Tumour necrosis factor alpha up-regulates protein kinase R (PKR)- activating protein (PACT) and increases phosphorylation of PKR and eukaryotic initiation factor 2-alpha in articular chondrocytes. Biochem Soc Trans 30: 886-889.
21. Gilbert SJ, Duance VC, Mason DJ (2004) Does protein kinase R mediate TNF-alpha- and ceramideinduced increases in expression and activation of matrix metalloproteinases in articular cartilage by a novel mechanism? Arthritis Res Ther 6: R46-R55.
22. Gilbert SJ, Blain EJ, Jones P, Duance VC, Mason DJ (2006a) Exogenous sphingomyelinase increases collagen and sulphated glycosaminoglycan production by primary articular chondrocytes: an in vitro study. Arthritis Res Ther 8: R89.
23. Gilbert SJ, Duance VC, Mason D (2006b) Protein kinase R: a novel mediator of articular cartilage degradation in arthritis. Curr Rheumatol Rev 2: 9-21.
24. Gilbert SJ, Blain EJ, Duance VC, Mason DJ (2008) Sphingomyelinase decreases type II collagen expression in bovine articular cartilage chondrocytes via the ERK signaling pathway. Arthritis Rheum 58: 209-220.
25. Hui W, Barksby HE, Young DA, Cawston TE, McKie N, Rowan AD (2005) Oncostatin M in combination with tumour necrosis factor {alpha} induces a chondrocyte membrane associated aggrecanase that is distinct from ADAMTS aggrecanase-1 or -2. Ann Rheum Dis 64: 1624-1632.
26. Hui W, Rowan AD, Richards CD, Cawston TE (2003) Oncostatin M in combination with tumor necrosis factor alpha induces cartilage damage and matrix metalloproteinase expression in vitro and in vivo. Arthritis Rheum 48: 3404-3418.
27. Jammi NV, Whitby LR, Beal PA (2003) Small molecule inhibitors of the RNA-dependent protein kinase. Biochem Biophys Res Commun 308: 50-57.
28. Jeffrey IW, Kadereit S, Meurs EF, Metzger T, Bachmann M, Schwemmle M, Hovanessian AG, Clemens MJ (1995) Nuclear localization of the interferon-inducible protein kinase PKR in human cells and transfected mouse cells. Exp Cell Res 218: 17-27.
29. Jimenez-Garcia LF, Green SR, Mathews MB, Spector DL (1993) Organization of the double-stranded RNA activated protein kinase DAI and virus-associated VA RNAI in adenovirus-2-infected HeLa cells. J Cell Sci 106: 11-22.
30. Kaempfer R (2003) RNA sensors: novel regulators of gene expression. EMBO Rep 4: 1043-1047.
31. Kim SH, Forman AP, Mathews MB, Gunnery S (2000) Human breast cancer cells contain elevated levels and activity of the protein kinase, PKR. Oncogene 19: 3086-3094.
32. Koromilas AE, Roy S, Barber GN, Katze MG, Sonenberg N (1992) Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. Science 257: 1685-1689.
33. Koshy PJ, Lundy CJ, Rowan AD, Porter S, Edwards DR, Hogan A, Clark IM, Cawston TE (2002) The modulation of matrix metalloproteinase and ADAM gene expression in human chondrocytes by interleukin-1 and oncostatin M: a time-course study using real-time quantitative reverse transcription-polymerase chain reaction. Arthritis Rheum 46: 961-967.
34. Kumar A, Haque J, Lacoste J, Hiscott J, Williams BR (1994) Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B. Proc Natl Acad Sci USA 91: 6288-6292.
35. Lakey RL, Cawston TE (2009) Sulfasalazine blocks the release of proteoglycan and collagen from cytokine stimulated cartilage and down-regulates metalloproteinases. Rheumatology (Oxford) 48: 1208-1212.
36. Langdon C, Kerr C, Hassen M, Hara T, Arsenault AL, Richards CD (2000) Murine oncostatin M stimulates mouse synovial fibroblasts in vitro and induces inflammation and destruction in mouse joints in vivo. Am J Pathol 157: 1187-1196.
37. Lee SB, Esteban M (1994) The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis. Virology 199: 491-496.
38. Litherland GJ, Dixon C, Lakey RL, Robson T, Jones D, Young DA, Cawston TE, Rowan AD (2008) Synergistic collagenase expression and cartilage collagenolysis are phosphatidylinositol 3-kinase/Akt signaling-dependent. J Biol Chem 283: 14221-14229.
39. Little CB, Barai A, Burkhardt D, Smith SM, Fosang AJ, Werb Z, Shah M, Thompson EW (2009) Matrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development. Arthritis Rheum 60: 3723-3733.
40. MacQuillan G, Caterina P, de Boer B, Allan J, Platten M, Reed W, Jeffrey G (2009) Ultra-structural localization of hepatocellular PKR protein using immuno-gold labeling in chronic hepatitis C virus disease. J Mol Histol 40: 171-176.
41. Matsumoto S, Kobayashi T, Katoh M, Saito S, Ikeda Y, Kobori M, Masuho Y, Watanabe T (1998) Expression and localization of matrix metalloproteinase-12 in the aorta of cholesterol-fed rabbits: relationship to lesion development. Am J Pathol 153: 109-119.
42. Milner JM, Rowan AD, Cawston TE, Young DA (2006) Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis. Arthritis Res Ther 8: R142.
43. Osman F, Jarrous N, Ben-Asouli Y, Kaempfer R (1999) A cis-acting element in the 3'-untranslated region of human TNF-alpha mRNA renders splicing dependent on the activation of protein kinase PKR. Genes Dev 13: 3280-3293.
44. Patel CV, Handy I, Goldsmith T, Patel RC (2000) PACT, a stress-modulated cellular activator of interferon-induced double-stranded RNA-activated protein kinase, PKR. J Biol Chem 275: 37993-37998.
45. Radtke S, Hermanns HM, Haan C, Schmitz-Van De Leur H, Gascan H, Heinrich PC, Behrmann I (2002) Novel role of Janus kinase 1 in the regulation of oncostatin M receptor surface expression. J Biol Chem 277: 11297-11305.
46. Rosendahl MS, Ko SC, Long DL, Brewer MT, Rosenzweig B, Hedl E, Anderson L, Pyle SM, Moreland J, Meyers MA, Kohno T, Lyons D, Lichenstein HS (1997) Identification and characterization of a pro-tumor necrosis factor-alpha-processing enzyme from the ADAM family of zinc metalloproteases. J Biol Chem 272: 24588-24593.
47. Sandy JD, Flannery CR, Neame PJ, Lohmander LS (1992) The structure of aggrecan fragments in human synovial fluid. Evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the Glu 373-Ala 374 bond of the interglobular domain. J Clin Invest 89: 1512-1516.
48. Scheuner D, Patel R, Wang F, Lee K, Kumar K, Wu J, Nilsson A, Karin M, Kaufman RJ (2006) Double-stranded RNA-dependent protein kinase phosphorylation of the alpha-subunit of eukaryotic translation initiation factor 2 mediates apoptosis. J Biol Chem 281: 21458-21468.
49. Takaishi H, Kimura T, Dalal S, Okada Y, D'Armiento J (2008) Joint diseases and matrix metalloproteinases: a role for MMP-13. Curr Pharm Biotechnol 9: 47-54.
50. Tam CL, Hofbauer M, Towle CA (2007) Requirement for protein kinase R in interleukin-1alpha-stimulated effects in cartilage. Biochem Pharmacol 74: 1636-1641.
51. Taylor S, Wakem M, Dijkman G, Alsarraj M, Nguyen M (2010) A practical approach to RT-qPCR-Publishing data that conform to the MIQE guidelines. Methods 50: S1-5.
52. van den Berg WB (2011) Osteoarthritis year 2010 in review: pathomechanisms. Osteoarthritis Cartilage 19: 338-341.
53. Vaughan-Thomas A, Dudhia J, Bayliss MT, Kadler KE, Duance VC (2008) Modification of the composition of articular cartilage collagen fibrils with increasing age. Connect Tissue Res 49: 374-382.
54. Vaughan-Thomas A, Gilbert SJ, Duance VC (2000) Elevated levels of proteolytic enzymes in the aging human vitreous. Invest Ophthalmol Vis Sci 41: 3299-3304.
55. Yoshihara Y, Nakamura H, Obata K, Yamada H, Hayakawa T, Fujikawa K, Okada Y (2000a) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis 59: 455-461.
56. Yoshihara Y, Nakamura H, Obata Ki, Yamada H, Hayakawa T, Fujikawa K, Okada Y (2000b) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis 59: 455-461.
57. Young DA, Lakey RL, Pennington CJ, Jones D, Kevorkian L, Edwards DR, Cawston TE, Clark IM (2005) Histone deacetylase inhibitors modulate metalloproteinase gene expression in chondrocytes and block cartilage resorption. Arthritis Res Ther 7: R503-512.
58. Zhu S, Romano PR, Wek RC (1997) Ribosome targeting of PKR is mediated by two double-stranded RNA-binding domains and facilitates in vivo phosphorylation of eukaryotic initiation factor-2. J Biol Chem 272: 14434-14441.